These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17919972)

  • 1. Single nucleotide polymorphisms and functional analysis of class II transactivator (CIITA) promoter IV in persistent HBV infection.
    Zhang X; Hong X; Deng G; Bai X
    J Clin Virol; 2007 Nov; 40(3):197-201. PubMed ID: 17919972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An analysis on the relationship between susceptibility to cirrhosis and polymorphisms at C-1350T and G-944C sites of CIITA gene promoter IV in chronic HBV carriers].
    Hong XJ; Zhang XQ; Bai XJ
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):38-42. PubMed ID: 18226342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not polymorphism but methylation of class II transactivator gene promoter IV associated with persistent HBV infection.
    He Y; Zhao Y; Zhang S; Chen W; Lin S; Yang Q; Liu J; Yang Y; Jin Y; Liu M
    J Clin Virol; 2006 Dec; 37(4):282-6. PubMed ID: 16996793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
    Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection.
    Kim YJ; Lee HS; Yoon JH; Kim CY; Park MH; Kim LH; Park BL; Shin HD
    Hum Mol Genet; 2003 Oct; 12(19):2541-6. PubMed ID: 12915457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of mannose-binding lectin polymorphisms and HBV outcome in a South Indian population.
    Fletcher GJ; Gnanamony M; Samuel P; Ismail AM; Kannangai R; Daniel D; Eapen CE; Abraham P
    Int J Immunogenet; 2010 Jun; 37(3):177-84. PubMed ID: 20193030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of TNFA polymorphisms with the outcomes of HBV infection].
    Liu Y; Guo XH; Du T; Li JH; Zhu XL; Gao JR; Lu LP; Gou CY; Li Z; Li H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):406-10. PubMed ID: 16086278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
    Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
    J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single nucleotide polymorphisms in the gene encoding the major histocompatibility complex class II transactivator (CIITA) in systemic lupus erythematosus.
    Koizumi K; Okamoto H; Iikuni N; Nakamura T; Kawamoto M; Momohara S; Ichikawa N; Furuya T; Kotake S; Taniguchi A; Yamanaka H; Kamatani N
    Ann Rheum Dis; 2005 Jun; 64(6):947-50. PubMed ID: 15897313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association between CCR5 promoter polymorphisms and hepatitis B virus infection].
    Chang HY; Ahn SH; Kim DY; Shin JS; Kim YS; Hong SP; Chung HJ; Kim SO; Yoo WD; Han KH
    Korean J Hepatol; 2005 Jun; 11(2):116-24. PubMed ID: 15980670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A non-synonymous single nucleotide polymorphism in IFNAR1 affects susceptibility to chronic hepatitis B virus infection.
    Zhou J; Smith DK; Lu L; Poon VK; Ng F; Chen DQ; Huang JD; Yuen KY; Cao KY; Zheng BJ
    J Viral Hepat; 2009 Jan; 16(1):45-52. PubMed ID: 18761606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin alpha V polymorphisms and haplotypes in a Korean population are associated with susceptibility to chronic hepatitis and hepatocellular carcinoma.
    Lee SK; Kim MH; Cheong JY; Cho SW; Yang SJ; Kwack K
    Liver Int; 2009 Feb; 29(2):187-95. PubMed ID: 18694400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in class II transactivator are associated with chronic hepatitis B virus infection in the Han Chinese population.
    Su M; Chen Z; Zheng J; Chen Y
    Int J Immunogenet; 2020 Oct; 47(5):435-442. PubMed ID: 32103629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA).
    Patarroyo JC; Stuve O; Piskurich JF; Hauser SL; Oksenberg JR; Zamvil SS
    Genes Immun; 2002 Feb; 3(1):34-7. PubMed ID: 11857059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of genotype and precore/basal core promoter mutations of hepatitis B virus in patients with chronic hepatitis B with acute exacerbation.
    Tsai WL; Lo GH; Hsu PI; Lai KH; Lin CK; Chan HH; Chen WC; Cheng JS; Liu YC; Huang TS; Ger LP; Lin HH
    Scand J Gastroenterol; 2008; 43(2):196-201. PubMed ID: 18224565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants in TNFRSF5 locus and association analysis with Hepatitis B virus (HBV) infection.
    Zhou G; Zhai Y; Dong X; Li Y; Zhang X; Zhang R; Li S; Li X; He F; Wei H; Chen X; Yao Z; Shen Y; Qiang B; He F
    Hum Mutat; 2004 Jan; 23(1):99-100. PubMed ID: 14695541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of TNF-alpha -308 polymorphism with the outcome of hepatitis B virus infection in Turkey.
    Basturk B; Karasu Z; Kilic M; Ulukaya S; Boyacioglu S; Oral B
    Infect Genet Evol; 2008 Jan; 8(1):20-5. PubMed ID: 17974504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-18 promoter polymorphisms and the disease progression of Hepatitis B virus-related liver disease.
    Migita K; Sawakami-Kobayashi K; Maeda Y; Nakao K; Kondoh S; Sugiura M; Kawasumi R; Segawa O; Tajima H; Machida M; Nakamura M; Yano K; Abiru S; Kawasaki E; Yatsuhashi H; Eguchi K; Ishibashi H
    Transl Res; 2009 Feb; 153(2):91-6. PubMed ID: 19138654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection.
    Ramezani A; Hasanjani Roshan MR; Kalantar E; Eslamifar A; Banifazl M; Taeb J; Aghakhani A; Gachkar L; Velayati AA
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1716-21. PubMed ID: 18761557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
    J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.